Cardiopulmonary Injury in the Syrian Hamster Model of COVID-19

Viruses. 2022 Jun 27;14(7):1403. doi: 10.3390/v14071403.

Abstract

The Syrian hamster has proved useful in the evaluation of therapeutics and vaccines for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). To advance the model for preclinical studies, we conducted serial sacrifice of lungs, large pulmonary vessels, and hearts from male and female Syrian hamsters for days 1-4, and 8 post-infection (dpi) following infection with a high dose of SARS-CoV-2. Evaluation of microscopic lung histopathology scores suggests 4 and 8 dpi as prime indicators in the evaluation of moderate pathology with bronchial hyperplasia, alveolar involvement and bronchiolization being key assessments of lung disease and recovery, respectively. In addition, neutrophil levels, red blood cell count and hematocrit showed significant increases during early infection. We present histological evidence of severe damage to the pulmonary vasculature with extensive leukocyte transmigration and the loss of endothelial cells and tunica media. Our evidence of endothelial and inflammatory cell death in the pulmonary vessels suggests endothelialitis secondary to SARS-CoV-2 epithelial cell infection as a possible determinant of the pathological findings along with the host inflammatory response. Lastly, pathological examination of the heart revealed evidence for intracardiac platelet/fibrin aggregates in male and female hamsters on 8 dpi, which might be indicative of a hypercoagulative state in these animals.

Keywords: COVID-19; SARS-CoV-2; blood; hamster; heart; lung; pathology; pulmonary vessels.

MeSH terms

  • Animals
  • COVID-19*
  • Cricetinae
  • Disease Models, Animal
  • Endothelial Cells
  • Female
  • Lung / pathology
  • Male
  • Mesocricetus
  • SARS-CoV-2

Grants and funding

This research received no external funding.